FDA Import Refusal SCS-1075133-9/11/1 — MERCK
The FDA refused shipment SCS-1075133-9/11/1 from MERCK (Canada) on Jul 6, 2020. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 6, 2020
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PAB68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75